The Global Market for Proteomics is Forecast to Reach US$30.5 Billion by 2024
Rapid
Technological Advancements and Rising R&D Funding Drive the Global Proteomics
Market, According to a New Report by Global Industry Analysts, Inc.
GIA
launches comprehensive analysis of industry segments, trends, growth drivers,
market share, size and demand forecasts on the global Proteomics market. The global market for Proteomics
is forecast to reach US$30.5 billion by the year 2024, driven by rapid
technological advancements, increasing R&D funding from various governments,
extensive usage to analyze target proteins for diagnosing various diseases, and
growing emphasis on personalized medicine.
The
global proteomics market is witnessing rapid technological advancements, and
increasing R&D funding from various governments. Advanced proteomics
solutions are finding extensive application in diagnostic services, drug
discovery, and other research fields. Proteomics is a promising approach
towards personalized medicine to treat several diseases, such as diabetes,
obesity, fatty liver, neurological diseases, and cancer. The proteomics market
is also benefitting from increasing penetration of technologies, such as
ElectroSpray Ionization-Liquid Chromatography-Mass Spectrometry (ESI-LC-MS).
Researchers globally are using sophisticated technologies, such as mass
spectrometry, protein fractionation systems, surface plasma resonance,
microarray, chromatography, and X-ray crystallography for comprehensive
analysis of proteins. The approach allows researchers to view cellular and
molecular functions for understanding complex biological processes. These
efforts towards targeted diagnosis as well as treatment are driving the
adoption of proteomics.
The
development of advanced dual mass analyzers, such as FT-MS, GC/MS, LC/MS, and
MALDI-TOF/TOF, along with improvements in gel electrophoresis and liquid
chromatography, and the availability of sophisticated algorithms to enable
database searching are facilitating proteomics research. Recent developments, such as multiple
reactions monitoring, are allowing researchers to quantify proteins in
cerebrospinal fluid to identify later phases of multiple sclerosis. Moreover,
proteomics is anticipated to be extensively used to analyze target proteins for
diagnosing various diseases. In addition, organizations, including the Human Proteome Organization, are encouraging the
development of advanced technologies and training related to proteomics. Proteomics
R&D is receiving policy and regulatory support from several governments.
While the Center for Biologics Evaluation and Research approves
proteomics-based biological products after validating their efficacy and
safety, the US FDA is evaluating the significance of analytical proteomic tools
to characterize biological solutions and validate biomarkers. However, the lack
of skilled researchers and high cost of instruments are restraining market
growth.
As stated by the new market research report on Proteomics,
the United States represents the largest market worldwide, followed by Europe. Emerging
economies of Asia and Latin America are poised to fuel future growth in the market
supported by socioeconomic growth, increased focus on biotechnological
research, strong government support, and increased outsourcing of proteomics
services to Asian countries.
Major
players in the market include ActivX Biosciences Inc., Agilent Technologies
Inc., Bio-Rad Laboratories Inc., Bruker Daltonics Inc., Caprion Biosciences
Inc., Digilab Inc., GE Healthcare,
Geneva Bioinformatics S.A., Merck KGaA,
PerkinElmer Inc., Shimadzu Corp., Millipore Sigma, Thermo Fisher Scientific
Inc., Waters Corp., and Xencor Inc., among others.
The
research report titled “Proteomics: A Global
Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market
trends, growth drivers, challenges and issues, mergers and acquisitions, and
other strategic industry activities of major global and niche companies. The
report provides market estimates and projections for all major geographic
markets, such as the United States, Canada, Japan, Europe (France, Germany,
Italy, UK, and the Rest of Europe), Asia-Pacific, Latin America, and Rest of
World.
For
enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
To
connect with us, visit our LinkedIn page.
Comments
Post a Comment